350 related articles for article (PubMed ID: 30775992)
1. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
2. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
3. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease.
Lim YY; Maruff P; Barthélemy NR; Goate A; Hassenstab J; Sato C; Fagan AM; Benzinger TLS; Xiong C; Cruchaga C; Levin J; Farlow MR; Graff-Radford NR; Laske C; Masters CL; Salloway S; Schofield PR; Morris JC; Bateman RJ; McDade E;
JAMA Neurol; 2022 Mar; 79(3):261-270. PubMed ID: 35099506
[TBL] [Abstract][Full Text] [Related]
4. Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease.
Lim YY; Hassenstab J; Goate A; Fagan AM; Benzinger TLS; Cruchaga C; McDade E; Chhatwal J; Levin J; Farlow MR; Graff-Radford NR; Laske C; Masters CL; Salloway S; Schofield P; Morris JC; Maruff P; Bateman RJ;
Ann Neurol; 2018 Sep; 84(3):424-435. PubMed ID: 30014553
[TBL] [Abstract][Full Text] [Related]
5. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.
Lim YY; Rainey-Smith S; Lim Y; Laws SM; Gupta V; Porter T; Bourgeat P; Ames D; Fowler C; Salvado O; Villemagne VL; Rowe CC; Masters CL; Zhou XF; Martins RN; Maruff P
Int Psychogeriatr; 2017 Nov; 29(11):1825-1834. PubMed ID: 28720165
[TBL] [Abstract][Full Text] [Related]
6. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
Lim YY; Hassenstab J; Cruchaga C; Goate A; Fagan AM; Benzinger TL; Maruff P; Snyder PJ; Masters CL; Allegri R; Chhatwal J; Farlow MR; Graff-Radford NR; Laske C; Levin J; McDade E; Ringman JM; Rossor M; Salloway S; Schofield PR; Holtzman DM; Morris JC; Bateman RJ;
Brain; 2016 Oct; 139(Pt 10):2766-2777. PubMed ID: 27521573
[TBL] [Abstract][Full Text] [Related]
7. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
8. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
[TBL] [Abstract][Full Text] [Related]
9. BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project.
van den Bosch KA; Verberk IMW; Ebenau JL; van der Lee SJ; Jansen IE; Prins ND; Scheltens P; Teunissen CE; Van der Flier WM
Neurobiol Aging; 2021 Dec; 108():146-154. PubMed ID: 34601245
[TBL] [Abstract][Full Text] [Related]
10. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
[TBL] [Abstract][Full Text] [Related]
12. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
[TBL] [Abstract][Full Text] [Related]
13. Associations of cerebrospinal fluid complement proteins with Alzheimer's pathology, cognition, and brain structure in non-dementia elderly.
Li M; Ma YH; Guo Y; Liu JY; Tan L;
Alzheimers Res Ther; 2024 Jan; 16(1):12. PubMed ID: 38238858
[TBL] [Abstract][Full Text] [Related]
14. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
[TBL] [Abstract][Full Text] [Related]
15. Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology.
Riphagen JM; van Hooren RWE; Kenis G; Verhey FRJ; Jacobs HIL
J Alzheimers Dis; 2022; 88(2):447-453. PubMed ID: 35662115
[TBL] [Abstract][Full Text] [Related]
16. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
[TBL] [Abstract][Full Text] [Related]
17. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington K; Bourgeat P; Bush AI; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2014; 9(1):e86498. PubMed ID: 24475133
[TBL] [Abstract][Full Text] [Related]
18. Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
Nascimento CM; Pereira JR; Pires de Andrade L; Garuffi M; Ayan C; Kerr DS; Talib LL; Cominetti MR; Stella F
J Alzheimers Dis; 2015; 43(1):81-91. PubMed ID: 25062900
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
20. Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia.
Huang CC; Liu ME; Chou KH; Yang AC; Hung CC; Hong CJ; Tsai SJ; Lin CP
Psychoneuroendocrinology; 2014 Jan; 39():94-103. PubMed ID: 24275008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
